Warner Pharmaceutical Factory: obtained the "Drug Registration Certificate" for Isoproterenol Hydrochloride Injection.

Warner Pharmaceuticals announced that it recently received the Drug Registration Certificate for Isoprenaline Hydrochloride Injection issued by the National Medical Products Administration, with specifications of 1ml:0.2mg and 5ml:1mg. The registration classification is Class 3 for chemical drugs. This injection is used for the treatment of cardiogenic or infectious shock, and is considered equivalent through consistency evaluation. Obtaining this certificate enriches the company's formulation product variety and optimizes the product structure, but will not have a significant impact on recent performance. Future sales are subject to uncertainty due to factors such as policies and the market.